How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
The Johns Hopkins Medical Institutions have become world renowned forexcellence in patient care for breakthrough discoveries in medical researchand as a training ground for the nation's finest physicians, nurses, publichealth experts and other health care professionals.
About Emageon Inc.
Emageon provides an enterprise-level advanced visualization andinfrastructure solution for the clinical analysis and management of digitalmedical images within multi-hospital networks, community hospitals anddiagnostic imaging centers. Emageon's web-enabled software providesphysicians in multiple medical specialties with dynamic tools to manipulateand analyze images in two and three dimensions. With these tools physicianshave the ability to better understand internal anatomic structure andpathology, which can improve clinical diagnoses, disease screening and therapyplanning. Emageon's open standards-based solution is designed to helpcustomers improve staff productivity, automate complex medical imagingworkflow, lower total cost of ownership and provide better service tophysicians and patients. On November 1, 2005, Emageon announced that it hadacquired Camtronics Medical Systems, Ltd. Camtronics, which was formerly awholly owned subsidiary of Analogic Corporation, is a leading provider ofcardiology image and information management systems. For more information,please visit www.emageon.com.
This press release contains forward-looking statements about Emageon whichrepresent the Company's current views with respect to, among other things,future events and financial performance. Any forward-looking statementscontained in this press release are based on Emageon's historical performanceand on current plans, beliefs and expectations. Actual results may differmaterially from those expressed or implied by such forward-looking statementsas a result of various risks, uncertainties and other factors beyond itscontrol. These risks, uncertainties and other factors include, among others,the risk that it may not compete successfully against larger competitors,risks associated with its history of operating losses, the risk that it maynot manage its growth effectively, risks associated with its reliance oncontinuing relationships with large customers, the risk of significant producterrors or product failures, its reliance on reseller arrangements forimportant components of its solution, the risk that it may not respondeffectively to changes in its industry, its customers' reliance on third partyreimbursements, and the potential impact on its business of FDA regulationsand other applicable health care regulations. Additional informationconcerning these and other factors that could affect Emageon's financial andoperating results may be found under the heading "Risk Factors" and elsewherein the Company's Form 10-K for the year ended December 31, 2004, which wasfiled with the Securities and Exchange Commission on March 31, 2005. Emageonundertakes no obligation to update these forward-looking statements or anyother information provided in this press release except as may be required bylaw.
SOURCE Emageon Inc.
News stories provided by third parties are not edited by "Site Publication" staff. For suggestions and comments, please click the Contact link at the bottom of this page.